Paid Clinical Trials Oklahoma City

Discover 725 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 725

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaEvaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Oklahoma City OK, Yukon OK, Frisco TX, McKinney TXshow 70 more

Code:

NCT06307665

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

BDA MDI

AS MDI

A Phase 1b Study of WU-NK-101 in Combination With CetuximabA Phase 1b Study of WU-NK-101 in Combination With Cetuximab

Recruiting

PHASE1

Sponsor:

Wugen, Inc.

Location:

Oklahoma City OK, Huntersville NC, Bronx NY, San Francisco CA

Code:

NCT05674526

Conditions

Colorectal Cancer Metastatic

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

WU-NK-101 - Dose Escalation

Cetuximab - Dose Escalation

WU-NK-101 - Cohort Expansion

Cetuximab - Cohort Expansion

Urolithin A Supplementation in Middle-aged Adults With ObesityUrolithin A Supplementation in Middle-aged Adults With Obesity

Recruiting

Sponsor:

University of Oklahoma

Location:

Oklahoma City OK

Code:

NCT05921266

Conditions

Obesity

Vascular Dementia

Cognitive Impairment

Eligibility Criteria

Sex: All

Age: 40 - 64

Healthy Volunteers: Not accepted

Interventions

Urolithin A

Placebo

Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

Recruiting

Sponsor:

North Texas Veterans Healthcare System

Location:

Oklahoma City OK, Dallas TX, Lubbock TX, Omaha NEshow 7 more

Code:

NCT02660866

Conditions

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo + background APT + SMT

Vorapaxar 2.08 mg/d + background APT + SMT.

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Oklahoma City OK, Lawton OK, Fort Smith AR, Joplin MOshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Interbody Systems: Post Market Clinical Follow-up StudyInterbody Systems: Post Market Clinical Follow-up Study

Recruiting

Sponsor:

K2M, Inc.

Location:

Oklahoma City OK, Shreveport LA

Code:

NCT04911257

Conditions

Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cervical or Lumbar Spinal fusion

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade GliomaA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City OK, Fort Worth TX, Dallas TX, Lubbock TXshow 103 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Recruiting

PHASE3

Sponsor:

GB002, Inc.

Location:

Oklahoma City OK, Plano TX, Dallas TX, Kansas City KSshow 51 more

Code:

NCT05934526

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Seralutinib

Generic Dry Powder Inhaler

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisAn Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Recruiting

Sponsor:

Pfizer

Location:

Oklahoma City OK, Houston TX, Littleton CO, Snellville GAshow 10 more

Code:

NCT06398626

Conditions

Colitis, Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Etrasimod

A Study of NX-1607 in Adults With Advanced MalignanciesA Study of NX-1607 in Adults With Advanced Malignancies

Recruiting

PHASE1

Sponsor:

Nurix Therapeutics, Inc.

Location:

Oklahoma City OK, Houston TX, Aurora CO, Chicago ILshow 5 more

Code:

NCT05107674

Conditions

Ovarian Cancer, Epithelial

Gastric Cancer

GastroEsophageal Junction (GEJ) Cancer

Head and Neck Squamous Cell Carcinoma

Metastatic or Unresectable Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NX-1607

Paclitaxel